DiscoverThe Rounds TableEpisode 119 - Semaglutide for MASH
Episode 119 - Semaglutide for MASH

Episode 119 - Semaglutide for MASH

Update: 2025-05-22
Share

Description

Send us a text

Welcome back, Rounds Table Listeners! This week we have a solo episode with Dr. John Fralick, discussing a recently published trial of the GLP-1 receptor agonist semaglutide for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). Here we go!

  1. Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis (0:006:33 ).

The Good Stuff:

  • Go Leafs go!

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 119 - Semaglutide for MASH

Episode 119 - Semaglutide for MASH

Dr. John Fralick and Dr. Michael Fralick